Vascular Pharmaceuticals is a biotech company based in Tarboro, North Carolina, that focuses on developing monoclonal antibody treatments for diabetic nephropathy. Established in 2005, the company operates within the biotechnology and healthcare sectors. Their most recent funding round was a $3.00M Series B investment on 07 January 2016.
Vascular Pharmaceuticals
A pioneering biotech company creating monoclonal antibody treatments for diabetic nephropathy.
Founded 2005
Series B
Total: $29.00M
Biotechnology, Health Care
General Information
Company Name
Vascular Pharmaceuticals
Founded Year
2005
Founders / Decision Makers
Industries
Biotechnology, Health Care
Funding Stage
Series B
BounceWatch is an independent company data service, not affiliated with Vascular Pharmaceuticals. To contact Vascular Pharmaceuticals, visit vascularpharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Biotechnology
About Vascular Pharmaceuticals
Taxonomy: Biotech, Monoclonal Antibodies, Diabetic Nephropathy, Drug Discovery, Medicine, Pharmaceuticals, North Carolina, Research and Development
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $3.00M | - |
|
07 Jan 2016 |
| Series A | $9.00M | 3 |
|
20 Mar 2015 |
| Debt Financing | $1.00M | - |
|
23 Apr 2013 |
| Series A | $16.00M | 5 |
|
12 Sep 2012 |
Vascular Pharmaceuticals Alternatives & Competitors
Vascular Pharmaceuticals vs
Advancing the future of immuno-oncology with innovative monoclonal antibody treatments
Series B
7 employees
Biotechnology, Health Care
Vascular Pharmaceuticals vs
Pioneering advanced treatments for cancer with innovative therapeutic antibodies and drug conjugates...
Series D
Biotechnology, Health Care
Vascular Pharmaceuticals vs
Innovative biotechnology solutions for metabolic disorders.
Series B
Biotechnology, Health Care
FAQ About Vascular Pharmaceuticals
A pioneering biotech company creating monoclonal antibody treatments for diabetic nephropathy.
Vascular Pharmaceuticals was founded in 2005.
Vascular Pharmaceuticals operates in Biotechnology and Health Care. Its work centres on Biotech, Monoclonal Antibodies, Diabetic Nephropathy and Drug Discovery.
Vascular Pharmaceuticals has completed 4 funding rounds, raising a total of $29.00M. The latest funding stage is Series B.
Top alternatives and competitors to Vascular Pharmaceuticals include GamaMabs Pharma, Agensys, DiObex, GLIKNIK INC., Ablexis, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vascular Pharmaceuticals and GamaMabs Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Vascular Pharmaceuticals, https://bouncewatch.com/company/vascular-pharmaceuticals, updated 26 December 2024. When citing, please name BounceWatch and link this page.
